Stock data
ABVC BioPharma, Inc. (ABVC)
ABVC BioPharma, Inc. (ABVC) reported net income of -US$7.91M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$7.15M | -US$7.91M | — |
| 2024 | US$0.51M | US$0.51M | -US$4.71M | -US$4.90M | — |
| 2023 | US$0.15M | -US$0.15M | -US$6.77M | -US$7.79M | — |
| 2022 | US$0.97M | US$0.68M | -US$15.11M | -US$16.42M | — |
| 2021 | US$0.36M | US$0.35M | -US$11.71M | -US$12.84M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$0.74M | — |
| 2026-03-31 | — | -US$1.56M | — |
| 2025-12-31 | — | -US$3.56M | — |
| 2025-09-30 | US$0.80M | -US$1.25M | — |
| 2025-06-30 | — | -US$2.26M | — |
| 2025-03-31 | — | -US$0.84M | — |
| 2024-12-31 | US$0.00M | -US$0.73M | — |
| 2024-09-30 | US$0.39M | -US$0.39M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.